Profit before interest, taxes and amortization: Xenon (XENE)
Xenon Pharmaceuticals (XENE) targets insurance systems and medicine in the treatment of severe neurological disorders. Patent protection precludes price wars, ensuring a unique market status. Expertise in ion channels enables the development of anticonvulsants without side effects. The current EBITDA value helps track cash flow, while the 0.00 metric indicates the status of operating profit.
Xenon (XENE) - metric breakdowns and financial figures
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Aggregate Debt to Equity Xenon Pharmaceuticals|XENE - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Xenon Pharmaceuticals Inc.|XENE - Company Aggregate Debts|Debts to Book Capitalization Xenon Pharmaceuticals|XENE - Company Long-Term Debt|Company Short-Term Loans and Borrowings Xenon Pharmaceuticals|Quick Liquidity Indicator xenon-pharma.com
- earnings and valuation multiples indicators:
XENE - Net Profit|Projected Future Earnings Xenon Pharmaceuticals|XENE - P/E Multiple|Projected Price to Earnings xenon-pharma.com|XENE - PEG Multiple|Company Value to EBITDA Xenon Pharmaceuticals|XENE - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Xenon Pharmaceuticals|XENE - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months xenon-pharma.com|XENE - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Xenon Pharmaceuticals
- sales and revenue indicators:
Summary company analytics:XENE (Xenon Corp)
This indicator captures the amount of cash generated by core operations before interest and taxes, allowing for an assessment of the business's actual ability to create capital. An analysis of the consolidated EBITDA reveals Xenon Pharmaceuticals (XENE) has a critical dependence on the outcome of a single drug trial, as any volatility in operating profit directly reflects the risks of a single-product structure within the biotech business.
Competitors of Xenon Pharmaceuticals (XENE)
BIIB: Operating profit before amortization|NBIX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization regencellbioscience.com|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ACAD|Operating profit before deduction of amortization VKTX|SUPN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Catalyst Pharmaceuticals (CPRX)|DNLI: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA HRMY (Harmony Biosciences Holdings, Inc.)|Income before deduction of interest, taxes and amortization BHVN|Amylyx - Operating profit EBITDA|TRVI - Operating profit EBITDA|Praxis Precision Medicines (PRAX) - Profit before payment of interest, taxes and amortization|anavex.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization CeriBell|Operating profit before deduction of amortization Prothena Corporation PLC (PRTA)|Operating profit EBITDA ALEC|Operating profit EBITDA Annexon Biosciences Inc. (ANNX)|Operating profit EBITDA OMER (Omeros)|NGNE - Operating profit before deduction of amortization|AC Immune SA - Operating profit EBITDA|Profit before interest, taxes and amortization Voyager Therapeutics Inc|NMRA (Neumora Therapeutics Inc) - Operating profit before deduction of amortization|Scilex Holding Company, Inc. (SCLX) - Operating profit EBITDA|Operating profit before deduction of amortization TVGN|ACOG (Alpha Cognition Corp) - Company profit before taxes, interest and amortization|Operating profit EBITDA CGTX|Operating income before deduction of amortization Inhibikase Therapeutics Inc|Operating profit EBITDA SAVA (Cassava)|ASRT - Operating profit before deduction of amortization|Coya - Operating profit EBITDA|VTGN - Operating profit EBITDA|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|ABOS (Acumen Pharmaceuticals Inc.) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization CervoMed Inc|Alterity Therapeutics Ltd (ATHE) - Operating income before deduction of amortization|Operating profit before deduction of amortization CLNN (Clene Inc.)|pepgen.com - Operating profit before amortization|Operating profit EBITDA JUNS (Jupiter Neurosciences)|Relmada Therapeutics Inc (RLMD) - Profit before interest, taxes and amortization|ANVS - Profit before payment of interest, taxes and amortization|GRCE (Grace Therapeutics, Inc.) - Operating profit before amortization|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Operating profit EBITDA MTVA|NRXS - Profit before interest, taxes and amortization|Helius Medical Technologies - Operating profit before deduction of amortization|Operating profit EBITDA Passage Bio Inc. PASG|NEUP - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NERV (Minerva Neurosciences Inc)|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Addex (ADXN)|Operating profit before deduction of amortization ALZN|Operating profit before amortization CYCN (Cyclerion)|Operating profit EBITDA PTIX|KTTA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cortigent CRGT|ATXI: Operating profit before amortization|BCLI - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ELYM|Operating profit before deduction of amortization ITCI|LBPH: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|NKGN: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Income before deduction of interest, taxes and amortization SAGE|Neurotrope - Operating profit EBITDA|TRVN - Operating profit EBITDA|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|anewmeds.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
